News und Analysen
Firan Technology Group Q2 Earnings Call Highlights
Key Points
- Interested in Firan Technology Group Co.? Here are five stocks we like better.
- FTG posted a record quarter in Q2 2026, with bookings up 89% to CAD 86.7 million, revenue up 8.2% to
EQS-News: Dividendenbekanntmachung
First Hydrogen Aktie: Exodus-Deal bleibt offen
Die Aktie von First Hydrogen beendete die vergangene Handelswoche mit einem Minus – trotzdem…
Der Beitrag First Hydrogen Aktie: Exodus-Deal bleibt offen erschien zuerst auf kapitalmarktexperten.de.
EQS-Adhoc: H&K AG: Heckler & Koch schließt Refinanzierung erfolgreich ab
PayPoint H2 Earnings Call Highlights
Key Points
- Interested in PayPoint plc? Here are five stocks we like better.
- PayPoint posted record annual results, with underlying pre-tax profit up to GBP 69 million, underlying EBITDA at GBP
Johnson Matthey H2 Earnings Call Highlights
Johnson Matthey (LON:JMAT) reported higher underlying profit, improved margins and stronger cash generation for fiscal 2025/2026, while management outlined progress on a restructuring strategy, the
Europas Innovationsfinanzierung im Umbruch: Die 2. Being Public Conference diskutiert die Zukunft des Kapitalmarkts
„Börsennotiz schafft Werte“ – GoingPublic Media bringt Vertreter börsennotierter Unternehmen, Börsenaspiranten und Kapitalmarktexperten in Frankfurt zusammen
- Deep Tech, KI und DefenseTech: Wie
EQS-News: 11880 Solutions integriert werkenntdenBESTEN in ChatGPT: Neue Ära der KI-gestützten Suche nach dem besten Anbieter
Horizon Quantum Computing Pte. CEO Says Software Is Key to Quantum's Next Leap
Key Points
- Interested in Horizon Quantum Computing Pte. Ltd.? Here are five stocks we like better.
- Horizon Quantum Computing is pitching itself as a software-first quantum company, with CEO
Bicara Therapeutics ASCO Data Bolster Ficerafusp Alfa in Head and Neck Cancer
Key Points
- Interested in Bicara Therapeutics Inc.? Here are five stocks we like better.
- Bicara Therapeutics said new ASCO data support ficerafusp alfa in first-line recurrent or metastatic
CAE Q4 Earnings Call Highlights
Key Points
- Interested in CAE Inc? Here are five stocks we like better.
- CAE reported higher fourth-quarter and full-year revenue, but profitability fell as weaker civil training demand, Middle
Endava Q3 Earnings Call Highlights
Key Points
- Interested in Endava PLC Sponsored ADR? Here are five stocks we like better.
- Endava missed on fiscal Q3 and cut its outlook after delayed client decisions, Middle East disruption
Euroseas Q1 Earnings Call Highlights
Key Points
- Interested in Euroseas Ltd.? Here are five stocks we like better.
- Euroseas posted stronger profitability despite lower revenue in Q1 2026, with net revenues of $55.84 million, net
EuroDry Q1 Earnings Call Highlights
Key Points
- Interested in EuroDry? Here are five stocks we like better.
- EuroDry returned to profitability in Q1 2026 as higher charter rates lifted net revenues 38.9% year over year to $12.8
Diploma H1 Earnings Call Highlights
Key Points
- Interested in Diploma PLC? Here are five stocks we like better.
- Diploma delivered a very strong first half with revenue up 17%, organic growth of 15%, and operating profit up 33% to
Telefónica Germany migriert die 4G/5G-Sprachdienste der ersten 100.000 Kunden auf die cloud-native IMS-Technologie von Mavenir
Meilenstein beim Umstieg auf IMS auf AWS erreicht: Betreiber stellt seinen Festnetz und Mobilfunkkundenstamm auf die Web-Scale-IMS-Lösung von Mavenir um
RICHARDSON, Texas, May 18, 2026 (GLOBE
Horizon Quantum Computing Pte. Lays Out Quantum Software Push at Needham Conference
Horizon Quantum Computing Pte. (NASDAQ:HQ) used its appearance at Needham & Company’s 21st annual Technology, Media, & Consumer
EQS-HV: FORIS AG: Bekanntmachung der Einberufung zur Hauptversammlung am 11.06.2026 in Bonn mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
EQS-HV: FORIS AG: Bekanntmachung der Einberufung zur Hauptversammlung am 29.06.2026 in Bonn mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
EQS-News: Einladung zur Hauptversammlung am 16. Juni 2026
Electrovaya Q2 Earnings Call Highlights
Electrovaya (NASDAQ:ELVA) reported higher fiscal second-quarter revenue and profitability while cautioning that supply chain delays and macroeconomic uncertainty could affect the timing of some
Bicara Therapeutics Touts Cancer Drug Progress Ahead of 2026 Pivotal Data
Bicara Therapeutics (NASDAQ:BCAX) said its lead cancer drug candidate, ficerafusp alfa, remains on track for pivotal data in head and neck cancer in mid-2026, as the company outlined its
Octave Specialty Group Q1 Earnings Call Highlights
Octave Specialty Group (NYSE:OSG) reported a narrower first-quarter loss and sharply higher adjusted earnings, driven by rapid growth in its insurance distribution business and contributions from
Bicara Therapeutics Q1 Earnings Call Highlights
Bicara Therapeutics (NASDAQ:BCAX) said it made progress during the first quarter of 2026 on the development and commercialization strategy for its lead drug candidate, ficerafusp alfa, or FICERA




